As of Feb 23
| -0.49 / -1.16%|
The 22 analysts offering 12-month price forecasts for Fresenius Medical Care AG & Co KGaA have a median target of 46.72, with a high estimate of 55.11 and a low estimate of 35.83. The median estimate represents a +12.29% increase from the last price of 41.61.
The current consensus among 23 polled investment analysts is to Buy stock in Fresenius Medical Care AG & Co KGaA. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.